-
1 Comment
Laurus Labs Limited is currently in a long term uptrend where the price is trading 70.0% above its 200 day moving average.
From a valuation standpoint, the stock is 1.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.7.
Laurus Labs Limited's total revenue rose by 76.6% to $13B since the same quarter in the previous year.
Its net income has increased by 271.4% to $3B since the same quarter in the previous year.
Finally, its free cash flow grew by 137.9% to $3B since the same quarter in the previous year.
Based on the above factors, Laurus Labs Limited gets an overall score of 5/5.
Exchange | NSE |
---|---|
CurrencyCode | INR |
ISIN | INE947Q01028 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Target Price | 564.9286 |
---|---|
Market Cap | 334B |
Beta | 1.08 |
PE Ratio | 93.23 |
Dividend Yield | 0.3% |
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LAURUSLABS.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025